Rectal Substance P Concentrations Are Increased in Ulcerative Colitis But Not in Crohn's Disease

The American Journal of Gastroenterology

Volumn 88, Issue 6, 1993, Pages 908-913

  Bernstein, Charles N ^a,b   Robert, Marie E ^a,b   Eysselein, Viktor E ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUBSTANCE P;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; EOSINOPHIL; FEMALE; HUMAN; MALE; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SPINAL GANGLION; STATISTICAL ANALYSIS; STOMACH BIOPSY; ULCERATIVE COLITIS;

ADULT; BIOPSY; COLITIS, ULCERATIVE; COMPARATIVE STUDY; CROHN DISEASE; FEMALE; HUMAN; INTESTINAL MUCOSA; MALE; RADIOIMMUNOASSAY; RECTUM; SUBSTANCE P;

EID: 0027193877     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1993.tb03075.x     Document Type: Article

References (25)

1. Functional roles for substance P‐containing neurones in the gastrointestinal tract
2. Neuroimmunology
3. Neuroendocrine modulation of the immune system. Possible implication for inflammatory bowel disease
4. Peptides and neurogenic inflammation
5. A substance P antagonist inhibits vagally induced increased in vascular permeability and bronchial smooth muscle contraction in the guinea‐pig
6. Evidence for substance P immunoreactive spinal afferents that mediate bronchoconstriction
7. Interneuronal substance P contributes to the severity of experimental arthritis
8. Increase in SP in primary afferent nerves during chronic pain
9. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease
10. Peptide containing nerve fibers in the gut wall in Crohn's disease
11. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases
12. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation
13. Receptor binding sites for substance P but not substance K. or neuromedin K are expressed in high concentrations by arterioles venules and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn's disease
14. Calcitonin gene‐related peptide and substance P decrease in rabbit colon during colitis: A time study
15. Modification of lymphocyte traffic by vasoactive neurotransmitter substances
16. Specific stimulation of human T lymphocytes by substance P
17. Substance P recognition by a subset of human T lymphocytes
18. Substance P binding properties and studies on cellular responses in guinea pig macrophages
19. Effect of neuropeptides on production of inflammatory cytokines by human monocytes
20. Mast cell heterogeneity: Effect of neurenteric peptides on histamine release
21. Neuromodulation of mast cell and basophil function
22. Substance P preceptor‐mediated chemotaxis of human monocytes
23. Substance P hinds to the formylpeptide chemotaxis receptor of the rabbit neutrophil
24. Local effector functions of capsaicin sensitive sensory nerve binding: Involvement of tachykinins